Beam Therapeutics Inc. (BEAM)

Beam Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	267.96	281.97	435.9	232.77	559.99	162.17
Short-Term Investments	807.01	568.77	753.98	845.37	405.65	137.5
Cash & Short-Term Investments	1,075	850.74	1,190	1,078	965.65	299.67
Cash Growth	16.12%	-28.50%	10.36%	11.65%	222.24%	226.27%
Receivables	-	-	-	-	300	-
Prepaid Expenses	23.58	27.41	21.17	14.76	7.36	8.65
Total Current Assets	1,099	878.15	1,211	1,093	1,273	308.32
Property, Plant & Equipment	205.29	216.28	237.81	234.13	186.98	125.37
Other Long-Term Assets	7.25	9.4	10.87	14.69	14.47	17.98
Total Assets	1,311	1,104	1,460	1,342	1,474	451.68
Accounts Payable	9.55	3.87	1.62	9.03	7.47	6.31
Accrued Expenses	36.29	36.13	35.05	30.72	56.87	11.96
Current Portion of Leases	12.69	13.47	12.78	12.23	9.83	6.34
Current Unearned Revenue	110.32	108.86	68.71	135.97	86.27	0.02
Other Current Liabilities	13.72	19.74	87.42	35.64	53	77.7
Total Current Liabilities	182.56	182.07	205.57	223.6	213.44	102.34
Long-Term Leases	138.73	147.96	159.91	168.63	137.82	101.31
Long-Term Unearned Revenue	10.16	33.22	109.89	202.18	262.3	0.39
Other Long-Term Liabilities	13.63	7.04	3.02	13.84	34.16	2.08
Total Liabilities	345.08	370.28	478.39	608.24	647.72	206.12
Common Stock	1.01	0.84	0.82	0.71	0.68	0.57
Additional Paid-In Capital	2,855	2,299	2,170	1,793	1,594	642.63
Retained Earnings	-1,891	-1,567	-1,190	-1,057	-768.27	-397.64
Comprehensive Income & Other	0.79	0.68	0.6	-2.43	-0.05	-0.01
Total Common Equity	966	733.55	981.33	733.47	826.74	245.56
Shareholders' Equity	966	733.55	981.33	733.47	826.74	245.56
Total Liabilities & Equity	1,311	1,104	1,460	1,342	1,474	451.68
Total Debt	151.42	161.43	172.69	180.86	147.64	107.64
Net Cash (Debt)	923.55	689.32	1,017	897.28	818	192.03
Net Cash Growth	20.93%	-32.23%	13.36%	9.69%	325.98%	216.82%
Net Cash Per Share	9.84	8.37	13.18	12.82	12.74	4.11
Filing Date Shares Outstanding	98.69	81.11	78.73	70.7	67.6	61.14
Total Common Shares Outstanding	98.58	81.06	78.71	69.58	67.26	55.98
Working Capital	915.99	696.08	1,005	869.3	1,060	205.98
Book Value Per Share	9.80	9.05	12.47	10.54	12.29	4.39
Tangible Book Value	966	733.55	981.33	733.47	826.74	245.56
Tangible Book Value Per Share	9.80	9.05	12.47	10.54	12.29	4.39
Machinery	84.41	79.79	69.67	54.79	35.23	18.83
Construction In Progress	10.24	2.53	5.28	5.2	7.35	15.88
Leasehold Improvements	102.25	101.2	100.19	85.8	57.76	12.71

Updated Nov 4, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q